Persons with rare diseases in India continue to encounter a maze of procedural and systemic obstacles when applying for disability certification, a prerequisite for accessing a range of government benefits and support schemes. A recent report by The Hindu highlights that, despite official attempts to simplify the certification process, the reality on the ground remains fraught with logistical, financial and regulatory challenges that disproportionately affect those with uncommon medical conditions.
What happened
The Hindu’s investigation documents a pattern of difficulty faced by patients with rare diseases across several states, with a focus on Andhra Pradesh. Applicants must obtain a medical assessment from a specialist recognized by the government’s disability assessment panels. For many rare conditions, such specialists are located only in major urban hospitals or research institutes, compelling patients to travel long distances, often at great personal expense, to secure the necessary documentation.
Even when patients succeed in reaching a certified medical facility, the list of ailments officially recognized for disability certification remains narrow. The report notes that numerous rare diseases are absent from the Schedule of Disabilities, meaning that a medical diagnosis alone does not guarantee eligibility for benefits such as pension schemes, subsidized medication, or reservation in education and employment.
Why it matters
Disability certification is the gateway to a suite of entitlements designed to mitigate the socioeconomic impact of chronic health conditions. Without a certificate, patients are excluded from financial assistance, priority healthcare, and legal protections afforded under the Rights of Persons with Disabilities Act, 2016. For rare‑disease patients—who often require costly, lifelong treatments and may experience social stigma—the lack of certification can exacerbate poverty, limit educational and occupational opportunities, and increase dependence on informal caregiving networks.
The report underscores that the procedural bottlenecks not only delay access to benefits but also impose indirect costs: lost wages from travel, accommodation expenses, and the emotional toll of navigating an opaque system. In a country where rare diseases affect an estimated 70 million people, these systemic barriers translate into a substantial public‑health equity concern.
Background and context
India’s disability framework was overhauled in 2016 to expand the definition of disability and increase the number of recognized conditions from 21 to 27. The revised schedule includes visual, hearing, locomotor, mental, and multiple disabilities, among others. However, the inclusion criteria rely heavily on measurable functional impairment, and the schedule does not comprehensively list rare diseases, many of which present with complex, multisystemic symptoms that defy simple classification.
The Ministry of Social Justice and Empowerment (MSJE) has issued guidelines for medical boards to assess disability, emphasizing the use of standardized assessment tools. Yet, the guidelines also acknowledge that “in the case of rare diseases, the certifying authority may seek expert opinion from a recognized specialist.” This clause, while well‑intentioned, places the onus on applicants to locate and fund specialist consultations—a requirement that is practically unmanageable for many families living in rural or low‑income settings.
Recent policy announcements have pledged to “digitize” the certification process and to expand the network of accredited medical assessors. Nonetheless, the Hindu’s field reporting indicates that implementation lags behind rhetoric, with few peripheral hospitals equipped to evaluate rare‑disease cases and limited awareness among local health officials about the specific documentation required.
Competing claims and uncertainty
Government officials have defended the existing framework, arguing that the certification process must balance rigor with fairness to prevent misuse of disability benefits. In a statement to the press, a senior MSJE spokesperson said that “the current list of recognized disabilities is based on extensive clinical evidence and aligns with international standards.” The ministry also cited ongoing efforts to update the schedule in consultation with medical experts and patient advocacy groups.
Patient advocacy organisations, however, dispute the adequacy of these measures. The Rare Disease India Network (RDI) released a position paper contending that the certification criteria are “outdated and not reflective of the lived realities of rare‑disease patients.” RDI’s director, Dr Anita Sharma, emphasized that many rare conditions produce fluctuating functional limitations that are difficult to capture through standard assessment scales, leading to under‑certification.
The Hindu’s report also notes that some state health departments have begun pilot projects to train district‑level physicians in rare‑disease assessment, but the pilots are limited in scope and have not yet produced measurable improvements in certification rates. Moreover, the lack of a centralized database of certified rare‑disease specialists creates information asymmetry, leaving patients uncertain about where to seek valid evaluations.
What to watch next
Several developments could reshape the certification landscape in the coming months:
1. Proposed amendment to the Schedule of Disabilities – Sources indicate that the MSJE is preparing a draft amendment to incorporate additional rare diseases, pending consultation with the National Institute of Health and Family Welfare. The timeline for public release remains unclear.
2. Digital certification platform rollout – The government’s e‑Disability portal is slated for an upgrade that would allow applicants to upload medical reports online and schedule virtual assessments with specialist panels. Monitoring the platform’s adoption rates and functionality will be critical to assessing whether it truly reduces travel burdens.
3. State‑level pilot expansions – Andhra Pradesh’s health ministry announced plans to expand its “Rare Disease Assessment Cells” to three more districts by the end of the fiscal year. Outcomes from these cells—such as average processing time and certification approval rates—will provide early indicators of policy efficacy.
4. Legal challenges – A recent public interest litigation filed in the Delhi High Court seeks a judicial directive for the central government to broaden the disability schedule and to mandate timely issuance of certificates for rare‑disease patients. The court’s ruling could compel legislative action.
Conclusion
The Hindu’s reporting paints a picture of a disability certification system that, while formally inclusive, remains practically inaccessible for many Indians living with rare diseases. The procedural demands of traveling to specialist centers, coupled with a narrow list of recognized conditions, create a double barrier that limits access to essential benefits.
Government officials argue that the existing safeguards are necessary to preserve the integrity of disability schemes, yet patient groups and legal advocates contend that the safeguards have become de facto exclusions. As policy proposals for schedule amendments, digital platforms and state‑level assessment cells move through the legislative and administrative pipelines, close scrutiny will be needed to ensure that reforms translate into tangible, equitable outcomes for the estimated tens of millions of rare‑disease patients across the country.
Sources
– “Hurdles persist for persons with rare diseases seeking disability certification,” The Hindu (National), July 2024, https://www.thehindu.com/news/national/andhra-pradesh/hurdles-persist-for-persons-with-rare-diseases-seeking-disability-certification/article71170223.ece
Story synopsis gathered from: The Hindu – National — source
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
